News

Believe It or Not, 1 Vape is the Same as Smoking 30 Cigarettes

More than 1.6 million U.S. middle and high school students reported vaping in 2023, and nearly 90% used flavored vapes. But America’s youth vaping epidemic may be no accident. UC San Francisco Professor of Medicine Pamela Ling, MD, MPH, is the Director of the UCSF Center for Tobacco Control Research

Year in Review: 2024

How This Cancer Drug Could Make Radiation a Slam Dunk Therapy

Radiation is one of the most effective ways to kill a tumor. But these therapies are indiscriminate, and they can damage healthy tissues. Now, UC San Francisco scientists have developed a way to deliver radiation just to cancerous cells. The therapy combines a drug to mark the cancer cells for

International Conference Features UCSF Breast Cancer Experts

Breast cancer experts from UCSF Health will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference. This year’s meeting will be held Dec. 10–13, 2024. Combining clinical, translational and basic

UCSF Health Experts Spotlight Advances at Hematology Conference

Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 66th Annual Meeting and Exposition. This year’s meeting will be held in San Diego Dec. 7-10. Widely considered the world’s leading event in malignant and

Molecular Zip Code Draws Killer T Cells to Brain Tumors

UCSF scientists have developed a “molecular GPS” to guide immune cells into the brain and kill tumors without harming healthy tissue. It is the first living cell therapy that can navigate through the body to a specific organ, addressing what has been a major limitation of CAR-T cancer therapies

Engineered Immune Cells May Be Able to Tame Inflammation

When the immune system overreacts and starts attacking the body, the only option may be to shut the entire system down and risk developing infections or cancer. But now, scientists at UC San Francisco may have found a more precise way to dial it down. The technology uses engineered T cells that act